Armotraz

Armotraz tablets containing active substance called as Anastrozole which is an inhibitor of Aromatase enzyme. It is active against Aromatase enzyme which is involved in estrogen synthesis. Armotraz is assort as third generation classification of Aromatase Inhibitor, includes in breast cancer treatment. In postmenopausal women, Armotraz is used to prohibit the Aromatase enzyme which is necessary to stop the estrogen production and involved in estrogen receptor positive breast cancer therapy. Armotraz is pharmacologically classified as; Aromatase inhibitor, Non-steroidal inhibitor of estrogen synthesis, Hormone receptor positive breast cancer drug

Anastrozole

Armotraz

1mg

Cipla





Armotraz indicated for

Armotraz used as promoting treatment:
Armotraz is mainly indicated in postmenopausal women who are suffered with hormone receptor positive early breast cancer.

First line choice:
Armotraz tablets are mediated as first line drug for the treatment involved in post-menopausal women with hormone receptor positive or hormone receptor unrecognized locally advanced breast cancer.

Second line choice:
Armotraz tablets are used as second drug choice in the post-menopausal women who are produce resistance in tamoxifen treatment. This may have indicated in patient with receptor negative disease.

Pharmacological action of Armotraz

The cancer cells growth in breast may induce and sustained by estrogen. An Aromatase enzyme which is involved in the aromatization of adrenal androgens (androstenedione & testosterone) which get converted into estrone and estradiol, which is the conclusion of estrogen biosynthesis. This enzyme is widely present in cells of ovary, liver, breast and also in malignant cells. By inhibiting this enzyme, abolition of estrogen biosynthesis occurs in peripheral tissues and also in cancer tissues. Reduction in circulating estradiol levels may leads to reduce the cancer cell growth.

Effect on estradiol:
The prescribed dose of 1mg of Armotraz which may leads to reduce the estradiol by relatively 70% within a period of 24 hours. The abolition of estradiol maintained after stopping the Armotraz therapy, for up to 6 days.

Effect on corticosteroids:
There is no variation occurs in cortisol & aldosterone secretion, no corticosteroid supplements is necessary.

Various endocrine effects:
No variation occurs in TSH; Armotraz only agitate the circulating levels of progesterone, androgens & estrogens.




PHARMACOKINETIC

Themaximum plasma concentration time occurs in a period of 2 hours. The absorption of Armotraz tablets after administration occurs very quickly .when Armotraz administered 30 minutes after food ingestion.The effect of concentration of Armotraz gets reduced by 16%, Tmax postponed from 2 to 5 hours

Only 40% of drug gets bound to the human plasma protein.

The metabolism of Armotraz arises by; Hydroxylation, Glucuronidation & N-Dealkylation These three metabolites are recovered in urine.

Nearly 85% of drug is eliminated through hepatic metabolism. Eliminated 10% in urine The terminal half-life period of Armotraz is 50 hours.





Blueberrypharma.com-img1

Armotraz 1mg
Brand Armotraz
Ingredients Anastrozole
Strength 1mg
Manufactured Cipla
Rating


Dosage regimens and administration of Armotraz

The prescribed dose of Armotraz is one tablet 1mg should be taken orally as a single dose. In metastatic breast cancer condition, the dose should be resumed until disease advancement. In ATAC ( Armotraz , tamoxifen, alone or in combination treatment), the dose of Armotraz should be followed for 5 years.

In specific populations

For pediatric
The Armotraz tablets are not allowed to use for pediatric patients, no drug safety is evaluated.

For geriatrics
Armotraz tablets should be administered with or without food. Dosage adjustment should not be suggested.

In renal & hepatic damaged patients
For mild & moderate renal impaired patients, dosage adjustment is not allowed. In severe condition, the usage of Armotraz should be in caution.

For mild or moderate hepatic impaired patients, dosage adjustment should not be suggested In severe condition, use with caution.

Over dosage

The maximum dose of Armotraz is 10mg should be given to post menopausal women with metastatic breast cancer. No special antidote is preferred, therapy should be symptomatic. Signs and symptoms associated to the over dosage of Armotraz should be monitored. Provide general supportive measures to the patients who are suffered with over dosage of Armotraz.

Common side effects

Pain, Arthralgia, Hypertension, Depression, Nausea, Vomiting, Rash, Osteoporosis, Fractures, Back pain, Insomnia, Headache, Bone pain, Hot flushes, Asthenia, Arthritis, Peripheral edema, Cough, Dyspnea, Pharyngitis, Lymphoedema If an adverse effect persists, discontinue the therapy.

For adjuvant therapy

Similar to that, some variations like; Vasodilatations, GI disorders, Hypercholestremia, Leucorrhea, UTI, Breast pain, Vulvovaginitis, Infection, Accidental injury, Flu like syndrome, Chest pain, Neoplasm, Cyst, Vaginal hemorrhage, Vaginitis, Ischemic cardiac disease, Venous thromboembolic events, Deep venous thromboembolic events, Ischemic Cerebrovascular event, Endometrial cancer

Ischemic cardiovascular events

During the Armotraz treatment, patients may affect with high incidence of ischemic cardiovascular events. This condition may occur in ATAC trials.

Bone effects

During Armotraz therapy, patient may suffer with diminishing the lumbar spine & total hip bone mineral density levels. This condition is occurring at high range in tamoxifen therapy, to reduce this adverse patient may frequently examined with bone mineral density.

Cholesterol

In Armotraz receiving patients have high chance in elevation of cholesterol.


Drug- drug interaction



  • Concurrent use of tamoxifen with Armotraz causes depletion in plasma concentration of Armotraz by 27%. This co administration did not affect the pharmacokinetic of tamoxifen ad its metabolites. Based on ATAC trials, this combination should be discontinued.
  • Armotraz with warfarin, causes increasing in bleeding effects. To avoid this problem patient must be examine with prothrombin time and INR value.
  • Co administration of Armotraz with cytochrome 450 enzymes, causes inhibition of CYP450
  • Armotraz tablets should not be used in combination with drugs containing estrogens, leads to reduce the pharmacological actions.


Contraindications

Armotraz tablets are contraindicated to pregnancy and premenopausal women, it may cause fetal harm.

Hypersensitivity reactions may occur; due to patients may contraindicate to the component present in the Armotraz tablets.




Pregnancy category: D Pregnancy category of Armotraz X, Armotraz tablets are not used in pregnancy and lactating period because it may cause fetal death.

Armotraz tablets stored between 20°C to 25°C (68°F to 77°F). Protect the container away from heat, moisture & light.

The missed dose should be skipped and follow the regular dosing schedule. If missed dose happens, must consult with practiced medical oncologist and follow the instructions.

Blueberrypharma.com-img2



Quick Contact




Prescription upload






PRESCRIPTION


Blueberrypharma.com , a fully licensed and regulated pharmacy medicine, takes all precautions to strictly abide by the laws and regulations set forth in the dispensing of prescription medications. By placing the order for your prescription medicines, you acknowledge and accept the following terms regarding the purchase of any prescription medicines.

Blueberrypharma.com will not dispense any prescription medication without a valid prescription from a licensed physician.

If you are ordering prescription medication(s), you hereby confirm that you will send us a scanned copy of your valid prescription(s) via email, fax, Whatsapp, or by post, and this prescription shall then be subject to the scrutiny of and approval by our qualified Pharmacists.

The drug information provided in the Blueberrypharma.com is for informative purposes only and this Website is not intended to provide diagnosis, treatment or medical advice. We are not liable for any adverse effects or harm to you as a result of your reliance on the information in the Website.

Blueberrypharma.com requires either the User or Customer or the Caregiver to confirm he/she is completely aware of the indications, side effects, drug interactions, effects of missed dose or overdose of the medicines he/she orders from us. It is imperative to seek professional advice from your physician before purchasing or consuming any medicine from Blueberrypharma.com

At Blueberrypharma.com , a Caregiver can order prescription medicines on your behalf.